MetaCap

Herbalife Ltd. (HLF)

NYSE: HLFHealth CareOther PharmaceuticalsUSD

12.65+0.07 (+0.56%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

HLF stock chart

Technical analysis

Key statistics

All statistics
Ex-dividend date
Feb 28, 2014
52-week range
7.56 – 20.40
Day range
12.55 – 12.85
Volume / Avg
1.54M / 1.54M
Beta
—
Next earnings
Nov 2, 2026

52-week range

$7.56$20.40

HLF stock today

Shares of Herbalife (HLF) finished higher on Oct 7 at $12.65, a gain of 0.56% or $0.07 per share, versus the S&P 500's 0.22% decline. At this level, HLF sits in the middle of its 52-week range of $7.56 to $20.40: 38.0% below the high, set on Feb 23, 2026 and 67.3% above the low. HLF is down 1.9% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 42.8%.

Herbalife trades at 8.1x its trailing twelve-month earnings per share of $1.57. Its forward P/E of 4.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Herbalife's next earnings report is expected on Nov 2, 2026.

Summary generated from market data by MetaCap's automated system. Methodology

About Herbalife

Company profile

Herbalife Ltd., together with its subsidiaries, provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers weight management products, including meal replacement, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism boosting teas; targeted nutrition products comprising functional beverages and dietary and nutritional supplements containing herbs, vitamins, minerals and other natural ingredients; energy, sports, and fitness products; and facial skin care, body care, and hair care products. The company also provides literature, promotional, and other materials, such as start-up kits, sales tools, and educational materials.

Industry
Other Pharmaceuticals
CEO
Mr. Stephan Paulo Gratziani
Headquarters
Los Angeles, CA
Employees
8,500
IPO year
2004

Analyst forecast

Forecast

Consensus (4 analysts)

none

Avg. price target

$17.00+34.39%

  • Strong buy 1
  • Buy 2
  • Hold 0
  • Sell 0
  • Strong sell 1

Target range

Low $9.00High $25.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Nov 2, 2026
EPS estimate
$0.73

Dividends

Dividend history
Annual dividend
$0.00
Last payment
$0.15
Ex-dividend date
Feb 28, 2014

HLF news

All HLF news

Herbalife peers

Health Care sector
HLF peer companies
CompanyPrice% ChgMarket capCompare
NUSNu Skin Enterprises Inc.4.80+1.27%$233.65Mvs HLF
ZSTKZeroStack Corp.4.77+0.42%$103.97Mvs HLF
ESYNEnerSyn Global Inc.2.06-1.90%$61.24Mvs HLF
COSMCosmos Health Inc.0.3209+0.44%$32.29Mvs HLF
MEDSDataMeds AI Inc.2.88-6.19%$8.16Mvs HLF
HKPDCellyan Biotechnology Co. Ltd Class A0.1037+0.78%$5.11Mvs HLF
CAHCardinal Health Inc.232.16-0.55%$53.76Bvs HLF
CORCencora Inc.317.25+0.28%$60.54Bvs HLF

Indexes, lists and sector

Herbalife stock FAQ

What is Herbalife's stock price today?

HLF last traded at $12.65 as of Oct 7, 4:00 PM EDT, up 0.56% on the day. Prices are delayed at least 15 minutes.

Does Herbalife pay a dividend?

Yes. Herbalife pays $0.00 per share annually. The most recent dividend of $0.15 had an ex-dividend date of Feb 28, 2014.

When is Herbalife's next earnings date?

Herbalife is expected to report earnings on Monday, November 2, 2026. Analysts expect EPS of $0.73.

What is HLF's P/E ratio?

HLF trades at a trailing P/E ratio of 8.06 and a forward P/E of 4.11.

Who is Herbalife's CEO?

Mr. Stephan Paulo Gratziani is the chief executive officer of Herbalife Ltd., which has about 8,500 employees.

Has HLF ever split its stock?

Yes. The most recent HLF stock split was a 2-for-1 split on May 15, 2018, one of 2 splits on record.

What is the HLF 52-week high?

The 52-week high for HLF is $20.40 and the 52-week low is $7.56. The stock is currently 38.0% below its high.

Compare HLF